🇺🇸 FDA

Company profile · Sponsor

Hemab

Hemab Therapeutics Holdings

COAG · NYSE biotech CAMBRIDGE, MA, USA
Pipeline
4
Drugs
0
Patents
0

Quick answer

Hemab (COAG) is a biotech company. headquartered in CAMBRIDGE, MA, USA. listed on NYSE. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker COAG
Exchange NYSE
Company type biotech
Headquarters CAMBRIDGE, MA, USA
SEC CIK 0002114044

Pipeline (4)

Search pipeline →

  1. HMB-001

    Hemab

    Glanzmann Thrombasthenia

    phase 2 small molecule active

    1 trial

  2. HMB-001

    Hemab

    Glanzmann Thrombasthenia

    phase 2 small molecule active

    1 trial

  3. HMB-002 (Part A)

    Hemab

    Von Willebrand Disease (VWD)

    phase 2 small molecule active

    1 trial

  4. Sutacimig

    Hemab

    Congenital Factor VII Deficiency

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is Hemab?

Hemab (COAG) is a biotech company. headquartered in CAMBRIDGE, MA, USA. listed on NYSE. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Hemab sponsor?

We track 4 ClinicalTrials.gov-linked programs for Hemab, including HMB-001 and 3 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Hemab company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.